# Addex Therapeutics Ltd.: Form 6-K, filed Jul 8, 2026

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 6-K
- Filed: 2026-07-08
- Accepted by EDGAR: Jul 8, 2026, 06:05 ET
- Period: 2026-07-08
- Accession: 0001171843-26-004524
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000117184326004524/f6k_070826.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000117184326004524/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000117184326004524/f6k_070826.htm

Filed Jul 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-004524. Last ingested by Listed: Nov 12, 2026, 17:13 ET. No prices; not investment advice.
